| Patient | Cleopatra |
|---|---|
| Date of birth | 1997-01-15 |
| Identifiers | MRN HR-AC003-SYN; SSN (made up) 000-03-7095 |
| Document date | 2026-11-01 |
| Author | Nefeli Arvanitis-Osei, MD |
| Custodian | St. Posthumous Health Center |
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
First prenatal visit at 9 weeks: the uterus is larger than dates; prenatal tests and an early ultrasound with maternal-fetal medicine. Concerns: At nine weeks her belly already looks bigger than it did at the same stage with her son, and the nausea is worse; she wants to know why; She wants to keep working as long as it is safe; Her partner is often away, and she wants a plan for appointments and the birth that she can manage with her household. [S]
| Allergy | Reaction | Status | Evidence |
|---|---|---|---|
| No known allergy | active | S |
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|---|---|---|---|---|
| Prenatal vitamin containing folic acid 0.4 mg, one tablet by mouth daily | One tablet by mouth daily | Oral route | 2026-03-03 | active | S |
| Ferrous sulfate 325 mg (65 mg elemental iron) oral tablet, one tablet by mouth every other day | One tablet every other morning with water or orange juice, apart from tea, coffee, and calcium | Oral route | 2026-03-03 | active | S |
| Doxylamine succinate 10 mg / pyridoxine hydrochloride 10 mg delayed-release tablet, two tablets by mouth at bedtime | Two tablets at bedtime; may add one in the morning if needed | Oral route | 2026-03-03 to 2026-05-12 | completed | S |
| Aspirin 81 mg delayed-release tablet, one tablet by mouth at bedtime | One tablet by mouth at bedtime from 12 weeks until delivery | Oral route | 2026-03-24 | active | S |
| Procedure | Dates | Status | Evidence |
|---|---|---|---|
| First-trimester ultrasound at 11 weeks with nuchal translucency: two live intrauterine fetuses; a thick dividing membrane with a twin-peak (lambda) sign at a fused anterior placental mass (dichorionic diamniotic); crown-rump lengths 45 and 46 mm; nuchal translucency 1.6 and 1.8 mm; nasal bones present; no structural abnormality seen; no fibroids; no features of a molar pregnancy | 2026-03-17 to 2026-03-17 | completed | S |
| Detailed anatomy ultrasound of both twins at 19 weeks: normal anatomy in each; dividing membrane confirmed; fused anterior placenta clear of the cervix; normal amniotic fluid around each twin; transvaginal cervical length 41 mm | 2026-05-12 to 2026-05-12 | completed | S |
| Transvaginal measurement of cervical length at 22 weeks: 39 mm, closed internal os, no funneling | 2026-06-02 to 2026-06-02 | completed | S |
| Growth ultrasound at 25 weeks: estimated weights 760 g (twin A) and 720 g (twin B), discordance 5 percent; normal amniotic fluid in each sac; normal umbilical artery Doppler | 2026-06-23 to 2026-06-23 | completed | S |
| Growth ultrasound at 33 weeks: estimated weights 2050 g (twin A, cephalic) and 1890 g (twin B, breech), discordance 8 percent; normal amniotic fluid in each sac; normal umbilical artery Doppler | 2026-08-18 to 2026-08-18 | completed | S |
| Date | Vaccine | Status | Evidence |
|---|---|---|---|
| 2026-03-03 | Influenza vaccine, 2025-2026 season, given in pregnancy | completed | S |
| 2026-08-18 | Tdap vaccine in pregnancy, 33 weeks | completed | S |
Historical biography with true dates. These events are not part of the synthetic care timeline.
| Historical date | History | Evidence |
|---|---|---|
| 47 BC, possibly 23 June | First pregnancy and birth: a son; nothing about the pregnancy or the birth is recorded | D (CLM-0005) |
No family medical history is documented in the logged sources. Family history of real relatives is recorded only from documented or retrospective sources and is never synthesized.
| Concern | Status | Evidence |
|---|---|---|
| At nine weeks her belly already looks bigger than it did at the same stage with her son, and the nausea is worse; she wants to know why | active | S |
| She wants to keep working as long as it is safe | active | S |
| Her partner is often away, and she wants a plan for appointments and the birth that she can manage with her household | active | S |
Most recent measures: Hemoglobin [Mass/volume] in Blood 11 on 2026-08-18; MCV [Entitic mean volume] in Red Blood Cells by Automated count 79 on 2026-03-03; Leukocytes [#/volume] in Blood by Automated count 9.4 on 2026-03-03; Platelets [#/volume] in Blood by Automated count 226 on 2026-08-18; Ferritin [Mass/volume] in Serum or Plasma 31 on 2026-06-23; Choriogonadotropin.beta subunit [Units/volume] in Serum or Plasma 152000 on 2026-03-03; Total score [EPDS] 6 on 2026-08-18; Fetal Crown Rump length US 46 on 2026-03-17; Fetal nuchal translucency measured by US 1.8 on 2026-03-17; Cervix [Length] US 39 on 2026-06-02; Glucose [Mass/volume] in Serum or Plasma --1 hour post 50 g glucose PO 128 on 2026-06-23; Fetal Body weight estimated by US 1890 on 2026-08-18; Sodium [Moles/volume] in Serum or Plasma 135 on 2026-06-02; Potassium [Moles/volume] in Serum or Plasma 3.5 on 2026-06-02; Creatinine [Mass/volume] in Serum or Plasma 0.55 on 2026-06-02 [S]
Strengths and supports: engagement in care [S]
| Problem | Clinical status | Verification | Code | Provenance |
|---|---|---|---|---|
| Uterus larger than dates in early pregnancy: 9 weeks by a certain last menstrual period, with the uterus about 12 to 13 weeks in size; nausea and vomiting heavier than in her first pregnancy; no bleeding; cause not yet known (multiple pregnancy, dating error, fibroids, or molar pregnancy) | resolved | confirmed | O26.841 | S — Synthetic presenting finding anchored to the documented conception in the winter of 41 to 40 BC; it resolves when the ultrasound explains it. |
| Nausea and vomiting of pregnancy, moderate (PUQE score 9); keeping fluids down; no weight loss or ketonuria | resolved | confirmed | O21.9 | S — Synthetic; nausea is common and often heavier in early pregnancy with a large uterus. |
| Iron deficiency anemia in pregnancy: hemoglobin 10.8 g/dL, MCV 79 fL, ferritin 14 ng/mL | active | confirmed | O99.011 | S — Synthetic finding; it echoes no documented diagnosis. |
| Twin pregnancy, dichorionic diamniotic, second pregnancy (gravida 2, para 1): two live fetuses with a thick dividing membrane and a twin-peak (lambda) sign at 11 weeks; dated by her last period, confirmed by the crown-rump lengths | active | confirmed | O30.041 | S — Synthetic modern diagnosis anchored to the documented twins of 40 BC; chorionicity is a modern finding and makes no claim about her real pregnancy. |
| Acute viral gastroenteritis at 22 weeks in a twin pregnancy, with mild dehydration and painless tightenings; no preterm labor (cervical length 39 mm); resolved with oral rehydration | resolved | confirmed | O98.512 | S — Synthetic intercurrent illness at an unscheduled visit, chosen to teach the assessment of tightenings and dehydration in a twin pregnancy; it echoes no documented illness. |
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
|---|---|---|---|---|---|---|
| 2026-03-03 | Hemoglobin [Mass/volume] in Blood | 10.8 | g/dL | 11-15 g/dL | Low | S |
| 2026-03-03 | MCV [Entitic mean volume] in Red Blood Cells by Automated count | 79 | fL | 80-100 fL | Low | S |
| 2026-03-03 | Leukocytes [#/volume] in Blood by Automated count | 9.4 | 10*3/uL | 4-13 10*3/uL | Normal | S |
| 2026-03-03 | Platelets [#/volume] in Blood by Automated count | 268 | 10*3/uL | 150-400 10*3/uL | Normal | S |
| 2026-03-03 | Ferritin [Mass/volume] in Serum or Plasma | 14 | ng/mL | 30-150 ng/mL | Low | S |
| 2026-03-03 | Choriogonadotropin.beta subunit [Units/volume] in Serum or Plasma | 152000 | m[IU]/mL | Wide normal range at 9 weeks, about 25,700 to 288,000 mIU/mL | Normal | S |
| 2026-03-03 | Total score [EPDS] | 6 | {score} | S | ||
| 2026-03-17 | Fetal Crown Rump length US | 45 | mm | Consistent with 11 weeks 2 days | Normal | S |
| 2026-03-17 | Fetal Crown Rump length US | 46 | mm | Consistent with 11 weeks 3 days | Normal | S |
| 2026-03-17 | Fetal nuchal translucency measured by US | 1.6 | mm | <=3.5 mm | Normal | S |
| 2026-03-17 | Fetal nuchal translucency measured by US | 1.8 | mm | <=3.5 mm | Normal | S |
| 2026-05-12 | Hemoglobin [Mass/volume] in Blood | 11.1 | g/dL | 10.5-15 g/dL | Normal | S |
| 2026-05-12 | Ferritin [Mass/volume] in Serum or Plasma | 24 | ng/mL | 30-150 ng/mL | Low | S |
| 2026-05-12 | Cervix [Length] US | 41 | mm | >=25 mm | Normal | S |
| 2026-06-02 | Cervix [Length] US | 39 | mm | >=25 mm | Normal | S |
| 2026-06-23 | Hemoglobin [Mass/volume] in Blood | 10.9 | g/dL | 10.5-15 g/dL | Normal | S |
| 2026-06-23 | Ferritin [Mass/volume] in Serum or Plasma | 31 | ng/mL | 30-150 ng/mL | Normal | S |
| 2026-06-23 | Platelets [#/volume] in Blood by Automated count | 241 | 10*3/uL | 150-400 10*3/uL | Normal | S |
| 2026-06-23 | Glucose [Mass/volume] in Serum or Plasma --1 hour post 50 g glucose PO | 128 | mg/dL | <=139 mg/dL | Normal | S |
| 2026-06-23 | Fetal Body weight estimated by US | 760 | g | About the 55th centile for 25 weeks | Normal | S |
| 2026-06-23 | Fetal Body weight estimated by US | 720 | g | About the 40th centile for 25 weeks; discordance 5 percent | Normal | S |
| 2026-06-23 | Total score [EPDS] | 7 | {score} | S | ||
| 2026-08-18 | Hemoglobin [Mass/volume] in Blood | 11 | g/dL | 11-15 g/dL | Normal | S |
| 2026-08-18 | Platelets [#/volume] in Blood by Automated count | 226 | 10*3/uL | 150-400 10*3/uL | Normal | S |
| 2026-08-18 | Fetal Body weight estimated by US | 2050 | g | About the 45th centile for 33 weeks | Normal | S |
| 2026-08-18 | Fetal Body weight estimated by US | 1890 | g | About the 30th centile for 33 weeks; discordance 8 percent | Normal | S |
| 2026-08-18 | Total score [EPDS] | 6 | {score} | S | ||
| 2026-06-02 | Sodium [Moles/volume] in Serum or Plasma | 135 | mmol/L | 133-145 mmol/L | Normal | S |
| 2026-06-02 | Potassium [Moles/volume] in Serum or Plasma | 3.5 | mmol/L | 3.3-5.1 mmol/L | Normal | S |
| 2026-06-02 | Creatinine [Mass/volume] in Serum or Plasma | 0.55 | mg/dL | 0.4-0.8 mg/dL | Normal | S |
| Date | Measure | Value | Unit | Provenance |
|---|---|---|---|---|
| 2026-03-03 | Body height | 165 | cm | S |
| 2026-03-03 | Body weight | 58 | kg | S |
| 2026-03-03 | Body mass index (BMI) [Ratio] | 21.3 | kg/m2 | S |
| 2026-03-03 | Systolic blood pressure | 108 | mm[Hg] | S |
| 2026-03-03 | Diastolic blood pressure | 66 | mm[Hg] | S |
| 2026-03-03 | Heart rate | 84 | /min | S |
| 2026-03-03 | Respiratory rate | 14 | /min | S |
| 2026-03-03 | Body temperature | 36.7 | Cel | S |
| 2026-03-03 | Oxygen saturation in Arterial blood by Pulse oximetry | 99 | % | S |
| 2026-03-17 | Body height | 165 | cm | S |
| 2026-03-17 | Body weight | 58.2 | kg | S |
| 2026-03-17 | Body mass index (BMI) [Ratio] | 21.4 | kg/m2 | S |
| 2026-03-17 | Systolic blood pressure | 106 | mm[Hg] | S |
| 2026-03-17 | Diastolic blood pressure | 64 | mm[Hg] | S |
| 2026-03-17 | Heart rate | 86 | /min | S |
| 2026-03-17 | Respiratory rate | 14 | /min | S |
| 2026-03-17 | Body temperature | 36.6 | Cel | S |
| 2026-03-17 | Oxygen saturation in Arterial blood by Pulse oximetry | 99 | % | S |
| 2026-05-12 | Body height | 165 | cm | S |
| 2026-05-12 | Body weight | 61.5 | kg | S |
| 2026-05-12 | Body mass index (BMI) [Ratio] | 22.6 | kg/m2 | S |
| 2026-05-12 | Systolic blood pressure | 104 | mm[Hg] | S |
| 2026-05-12 | Diastolic blood pressure | 62 | mm[Hg] | S |
| 2026-05-12 | Heart rate | 88 | /min | S |
| 2026-05-12 | Respiratory rate | 14 | /min | S |
| 2026-05-12 | Body temperature | 36.7 | Cel | S |
| 2026-05-12 | Oxygen saturation in Arterial blood by Pulse oximetry | 99 | % | S |
| 2026-06-02 | Body height | 165 | cm | S |
| 2026-06-02 | Body weight | 61 | kg | S |
| 2026-06-02 | Body mass index (BMI) [Ratio] | 22.4 | kg/m2 | S |
| 2026-06-02 | Systolic blood pressure | 102 | mm[Hg] | S |
| 2026-06-02 | Diastolic blood pressure | 60 | mm[Hg] | S |
| 2026-06-02 | Heart rate | 98 | /min | S |
| 2026-06-02 | Respiratory rate | 16 | /min | S |
| 2026-06-02 | Body temperature | 37.4 | Cel | S |
| 2026-06-02 | Oxygen saturation in Arterial blood by Pulse oximetry | 99 | % | S |
| 2026-06-23 | Body height | 165 | cm | S |
| 2026-06-23 | Body weight | 64.2 | kg | S |
| 2026-06-23 | Body mass index (BMI) [Ratio] | 23.6 | kg/m2 | S |
| 2026-06-23 | Systolic blood pressure | 108 | mm[Hg] | S |
| 2026-06-23 | Diastolic blood pressure | 66 | mm[Hg] | S |
| 2026-06-23 | Heart rate | 90 | /min | S |
| 2026-06-23 | Respiratory rate | 16 | /min | S |
| 2026-06-23 | Body temperature | 36.7 | Cel | S |
| 2026-06-23 | Oxygen saturation in Arterial blood by Pulse oximetry | 99 | % | S |
| 2026-08-18 | Body height | 165 | cm | S |
| 2026-08-18 | Body weight | 70.5 | kg | S |
| 2026-08-18 | Body mass index (BMI) [Ratio] | 25.9 | kg/m2 | S |
| 2026-08-18 | Systolic blood pressure | 114 | mm[Hg] | S |
| 2026-08-18 | Diastolic blood pressure | 72 | mm[Hg] | S |
| 2026-08-18 | Heart rate | 92 | /min | S |
| 2026-08-18 | Respiratory rate | 16 | /min | S |
| 2026-08-18 | Body temperature | 36.8 | Cel | S |
| 2026-08-18 | Oxygen saturation in Arterial blood by Pulse oximetry | 99 | % | S |
| Date | Purpose | Status | Provenance |
|---|---|---|---|
| 2026-03-03 | First prenatal visit at 9 weeks: the uterus is larger than dates; prenatal tests and an early ultrasound with maternal-fetal medicine | finished | S |
| 2026-03-17 | Prenatal visit at 11 weeks with the maternal-fetal medicine consultation and first-trimester ultrasound | finished | S |
| 2026-05-12 | Prenatal visit at 19 weeks with the detailed anatomy scans and cervical length | finished | S |
| 2026-06-02 | Same-day sick visit for vomiting, diarrhea, and tightenings at 22 weeks | finished | S |
| 2026-06-23 | Prenatal visit at 25 weeks: growth scan, glucose challenge, and blood count | finished | S |
| 2026-08-18 | Prenatal visit at 33 weeks: growth scan, Tdap, and the delivery plan | finished | S |
| Intervention | Status | Guideline | Provenance |
|---|---|---|---|
| First prenatal visit: blood count, ferritin, quantitative hCG, blood group and antibody screen, rubella immunity, hepatitis B surface antigen, HIV, syphilis, and hepatitis C tests; urine culture; influenza vaccine; prenatal vitamin with folic acid | completed | GL-USPSTF-AB, GL-CDC-PREGVAX | S |
| Maternal-fetal medicine consultation with a first-trimester ultrasound at 11 weeks for a uterus large for dates: dating, the number of fetuses and, if more than one, chorionicity; nuchal translucency; and fibroids or a molar pregnancy | completed | GL-ACOG-DUE-2017, GL-ACOG-MULTI-2021 | S |
| Nausea and vomiting: small, frequent, bland meals, ginger, and doxylamine with pyridoxine at bedtime; return for vomiting that stops her keeping fluids down, weight loss, or dizziness | completed | GL-ACOG-NVP-2018 | S |
| Iron deficiency anemia: ferrous sulfate 325 mg every other day; blood count and ferritin at the anatomy-scan visit, with intravenous iron in the second trimester if there is no response | completed | GL-ACOG-ANEMIA-2021 | S |
| Mood: EPDS in each trimester and after the birth | completed | GL-ACOG-MH-2023 | S |
| Twin pregnancy care (dichorionic diamniotic): aneuploidy screening by nuchal translucency for each fetus and cell-free DNA, with chorionic villus sampling or amniocentesis available; detailed anatomy scans at 18 to 22 weeks; growth scans every four weeks from 20 weeks with discordance calculated; prenatal visits every two to four weeks; weight gain of about 17 to 25 kg; weekly fetal testing may be considered from 36 weeks | completed | GL-ACOG-MULTI-2021, GL-ACOG-ANEU-2020 | S |
| Preeclampsia prevention: aspirin 81 mg at bedtime from 12 weeks until delivery, because a twin pregnancy is a high-risk factor; blood pressure and urine protein at every visit | completed | GL-USPSTF-ASA-2021, GL-ACOG-MULTI-2021 | S |
| Preterm birth: teaching on the signs of preterm labor; cervical length at the anatomy scan; no cerclage, pessary, progesterone, or bed rest for a twin pregnancy alone; antenatal corticosteroids if birth before 34 weeks is threatened | completed | GL-ACOG-PTB-2021, GL-ACOG-MULTI-2021 | S |
| Gestational diabetes: one-hour glucose challenge at 24 to 28 weeks | completed | GL-ACOG-GDM-2018 | S |
| Delivery plan: birth at 38 0/7 to 38 6/7 weeks in a hospital with a neonatal intensive care unit; vaginal birth while twin A is head down, with an epidural and the operating room ready for twin B; active management of the third stage for the higher risk of hemorrhage; group B streptococcus swab at 36 to 37 weeks; RSV vaccine at 32 to 36 weeks once the season begins in September; Tdap at 27 to 36 weeks | completed | GL-ACOG-831-2021, GL-ACOG-MULTI-2021, GL-CDC-PREGVAX | S |
| Goal | Target | Status | Outcome | Provenance |
|---|---|---|---|---|
| The cause of the large uterus and the dating of the pregnancy established at the 11-week scan | 2026-03-17 | completed | Dichorionic diamniotic twins; dating by her last period confirmed by the crown-rump lengths | S |
| An informed choice about aneuploidy screening by 14 weeks | 2026-03-17 | completed | Chose nuchal translucency for each twin with cell-free DNA; declined diagnostic testing for now | S |
| Hemoglobin and ferritin in the normal range for pregnancy by the third trimester | 2026-08-18 | completed | Ferritin 31 ng/mL at 25 weeks; hemoglobin 11.0 g/dL at 33 weeks | S |
| Growth discordance under 20 percent at every growth scan | 2026-08-18 | completed | Discordance 5 percent at 25 weeks and 8 percent at 33 weeks | S |
| A written delivery plan agreed by 34 weeks | 2026-08-18 | completed | Planned birth at 38 weeks 0 days in the hospital, with a vaginal birth while twin A is head down, an epidural, and the operating room ready | S |